Virometix raised €13M in a funding round in Nov 2025. The company is based in Schlieren, Switzerland. Data as of 23 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
